US-Guided Preemptive Brachial Plexus Blockade May Reduce Post-operative Pain: a Randomized Study

Intense e recurrent nociceptive stimulation, which occurs in the postoperatively, can trigger sensitization of the peripheral and central nociceptive pathway, leading to chronic pain. Patients with rotator cuff injury often present to surgery due to referred moderate to intense long-term pain. During the immediate postoperative period, pain is rare due to the routine administration of a brachial plexus blockade as an adjuvant to improve the quality of postoperative analgesia. However, after the second postoperative day, the effect of the blockade ceases, and the pain becomes high and hard to treat, leading the patient to request administration of more frequent and more potent analgesics. The aim of this project is to assess the postoperative analgesic benefits of a brachial plexus blockcade 2 days before arthroscopic surgical correction of rotator cuff injury by reducing the sensitization of the nociceptive pathway.

Study Overview

• Status: Completed
• Conditions: Postoperative Pain; Rotator Cuff Injuries
• Intervention / Treatment: Drug: Standard group; Drug: Preemptive group

Detailed Description

This is a prospective, controlled, blinded, randomized trial design, based on the PICO structured question: "Brachial plexus block 48 h before arthroscopic surgery for correction of rotator cuff tear in a patient with chronic shoulder pain can influence the postoperative pain? The project will be submitted to the Research Ethics Committee and, after its approval, will be submitted to the Ethics Committee of the institution where the research will be carried out. After approval at these instances and registration at clinicaltrials.gov, a sample of 70 individuals will be selected from a population of patients scheduled for arthroscopic correction of rotator cuff tears. Study subjects will be randomly distributed by electronic draw into two groups: the standard group (SG) and the preemptive group (PG). All patients in both groups will be instructed on the visual analogue (AVS) and numeric pain scales (NPS). The groups will be drawn by a member of the team who will only have the function of controlling the flow of the groups, without participating in any evaluation regarding the trial protocol. All patients in the study will be submitted to BPB and sedation immediately before the surgery. GP patients will undergo BPB 48 h before surgery to try to desensitize the nociceptive pathway. Individuals in the stardard group (SG) will be submitted to an ultrasonographic examination of the topography of the shoulder to be operated on, without knowing whether any therapeutic procedure was performed or just an examination. Both components of both groups will be instructed to use a sling after the procedure 48 h before surgery (BPB or US exam).

INCLUSION CRITERIA: patients scheduled for arthroscopic correction of rotator cuff injury, body mass index < 35 kg/m², shoulder pain complaint for at least 3 months and intensity ≥ 4 (0 to 10) on the day of the pre-anesthetic consultation , ASA I or II, mental and legal capacity to spontaneously accept and sign the informed consent form.

EXCLUSION CRITERIA: allergy to any drug in the study protocol, refusal to participate, contraindication to any substance or technique described in the protocol, intellectual or other limitations that make it difficult to understand the questions and guidelines related to the project protocol, intercurrence at the time of the BPB, not properly installing the BPB (assessment of its sensory effect).

SAMPLE SIZE. The authors carried out an unpublished study comparing two groups of 30 patients for arthroscopic correction of cuff injuries under BPB guided by a peripheral nerve stimulator associated with general anesthesia. One group received BPB 2 days before surgery to assess the possible advantage of reducing the sensitization of chronically stimulated nociceptive pathways in reducing postoperative pain. It is known that postoperative pain in this scenario becomes more intense from the third day on. In this study, pain on the third postoperative night had a mean score of 3.68 (END - 0 to 10), with a standard deviation of 3.04. Our goal is to reduce scores below 3 on the third postoperative night (we will consider an average of 2). Using Pocock's formula12, for a significance level of 95% and a statistical power of 80%, the calculated sample size was 25.86. We increased it to 35 to compensate for losses, with a total of 70 patients in the study.

TECHNIQUE. After guidance on the protocol and signature of the TCLE (Annex 1), the 70 individuals from the study sample will be randomly distributed into two groups (preemptive group - PG; standard group - SG) using an electronic draw offered on the website www.random.org. After distributing the numbers, the same professional responsible for it will number 70 brown envelopes from 1 to 70 and inside each one of them will put the name of the group that corresponds to it, according to the order established by the draw. The order of arrival of patients at the pre-anesthetic evaluation office will correspond to the order in which the envelopes are numbered. The professional responsible for drawing lots and distributing envelopes will not participate in anesthesia or evaluations and will keep the draw secret for security and any clarifications. In the pre-anesthetic consultation, patients with shoulder pain for more than 3 months and with a pain score on the day of the consultation ≥ 4 who agreed to participate in the study will respond to the brief pain inventory validated for Brazilian Portuguese13, to the short version of the questionnaire McGill's pain test14 and the quality of life questionnaire validated for Brazilian Portuguese (WHOQOL-SRPB)15.

After basic monitoring (electrocardioscopy - ECG, oximetry and non-invasive blood pressure - NIBP) and obtaining venous access, PG patients will receive BPB 48 h before surgery. The BPBs in the study will be US-guided. In preemptive BPB (PG), 15 ml of 1% ropivacaine will be injected. Patients in the SG will be submitted to an ultrasound examination of the brachial plexus, and even if they are not submitted to a puncture or invasive process, they will not know which group they will participate in to keep them covered. The anesthesiologist who performs the previous BPB may be the same one who will perform the BPB for that patient on the day of the surgery, since the mark of the first BPB will hardly have disappeared, making it practically impossible to cover up this sign. Likewise, the anesthesiologist who will perform the previous ultrasound examination may be the same one who will perform the BPB on the day of the surgery. All patients in both groups will be instructed to use a sling on the shoulder to be operated after the previous BPB or previous ultrasound examination, in an attempt to keep the group covered. The anesthesiologist conducting the sedation and assessment of patients will not be able to participate in the blocks or examination of the patient who will be administering the sedation or performing the assessment. Patients will be instructed to use dipyrone 1 g every 6 hours and paracetamol (500 mg) associated with codeine (30 mg) in case of pain ≥ 4 in the two days prior to surgery. On the day of surgery, all patients will be asked about the intensity of pain at that time (record). After that, patients in both groups will undergo basic monitoring (as mentioned above) upon entering the operating room, obtaining venous access, sedation with 3 mg of midazolam and fentanyl 50 µg, and BPB with the same technique and block material preemptive. After confirming the installation of the BPB, the patient will receive intravenous ketamine 15 mg. The adjuvant medication will be dipyrone 30 mg/kg, cephalozine 2 g, ketoprofen 100 mg, ondansetron 8 mg, dexamethasone 4 mg. Hemodynamic changes will be managed at the discretion of the providing anesthetist.

It is routine for the team to perform surgeries in the morning and to discharge patients in the late afternoon, except for exceptions due to intercurrences. In the postoperative period, all patients will receive dipyrone 1 g every 6 hours and the combination of paracetamol (500 mg) and codeine (30 mg) as rescue for postoperative pain ≥ 4.

All patients will receive telephone contact from the evaluator between 5:00 pm and 7:00 pm of the first three postoperative days, when they will respond when the first pain ≥ 4 occurred in the postoperative period, what is the consumption of paracetamol/codeine. In the first two days, the level of pain at the time of the interview and the average pain during the day will be recorded. On the third day, patients will answer the brief pain inventory questionnaire13, the McGill pain questionnaire14 and the quality of life questionnaire (WHOQOL)15

• Study Type: Interventional
• Enrollment (Actual): 70
• Phase: Not Applicable

Contacts and Locations

Study Locations

• Brazil
  • São Paulo, Brazil, 01246-903
    • Hospital das Clínicas - Faculdade de Medicina da Universidade de Sao Paulo

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Child; Adult; Older Adult
• Accepts Healthy Volunteers: No

Description

Inclusion Criteria:

• Body mass index < 35 kg/m²
• shoulder pain lasting > 3 months
• pain score > 3 (visual analog scale and verbal response 0 to 10) on the day of pre anesthetic evaluation
• American Society of Anesthesiologists score I or II
• mentally and legally capable to understand and consent to study participation.

Exclusion Criteria:

• Allergy to any medication of the trial
• refusal to participate, contraindication to any medication or technique described in the protocol of the trial
• complications from, or failure of brachial plexus blockade.

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Other
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: Quadruple

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Placebo Comparator: Standard group; Patients from this group will undergo only ultrasound examination of the brachial plexus, two days before the surgery. On the day of surgery they will undergo ultrasound-guided brachial plexus blockade (interscale access; 15 ml 1% ropivacaine and sedation (midazolam 3 mg, fentanyl 50 µg and 15 mg ketamine.	Drug: Standard group; Ultrasound examination of the brachial plexus 2 days before the surgery. Ultrasound guided brachial plexus blockade and sedation on the day of surgery.; Other Names: Ultrasound examination
Experimental: Preemptive group; Patients from this group will undergo ultrasound-guided brachial plexus blockade, two days before the surgery. On the day of surgery they will undergo ultrasound-guided brachial plexus blockade (interscale access; 15 ml 1% ropivacaine and sedation (midazolam 3 mg, fentanyl 50 µg and 15 mg ketamine.	Drug: Preemptive group; Ultrasound guided brachial plexus blockade 2 days before the surgery. Ultrasound guided brachial plexus blockade and sedation on the day of surgery.; Other Names: Ultrasound guided blockade

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Pain score on third postoperative day	Pain assessment through verbal numerical scale of pain (from 0 to 10).	Three days

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Pain scores before surgery.	Postoperative pain through verbal numerical scale of pain (from 0 to 10)	Just before surgery
Pain cores on three postoperative days.	Postoperative pain through verbal numerical scale os pain (from 0 to 10)	Three days.
Opioid consumption	Opioid consumption (mg codeine) two days before surgery	Two days before surgery
Opioid consumption	Opioid consumption (mg codeine) during the first three postoperative days	Three days

Collaborators and Investigators

• Sponsor: University of Sao Paulo General Hospital
• Investigators: Principal Investigator: Joaquim Vieira, Professor, University of Sao Paulo School of Medicine

Study record dates

Study Major Dates

• Study Start (Actual): December 14, 2022
• Primary Completion (Actual): March 1, 2024
• Study Completion (Actual): March 10, 2024

Study Registration Dates

• First Submitted: June 24, 2019
• First Submitted That Met QC Criteria: July 1, 2019
• First Posted (Actual): July 2, 2019

Study Record Updates

• Last Update Posted (Actual): April 16, 2024
• Last Update Submitted That Met QC Criteria: April 14, 2024
• Last Verified: April 1, 2024

More Information

Terms related to this study

• Keywords: Postoperative pain; Preemptive analgesia; Rotator cuff injuries
• Additional Relevant MeSH Terms: Pathologic Processes; Postoperative Complications; Pain; Neurologic Manifestations; Wounds and Injuries; Rupture; Shoulder Injuries; Tendon Injuries; Pain, Postoperative; Rotator Cuff Injuries
• Other Study ID Numbers: CAAE 09012419.3.0000.5501

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO
• IPD Plan Description: The data will only be available for researchers after the end of the data collection and analysis on request.

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No